The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJz Capital Regulatory News (JZCP)

Share Price Information for Jz Capital (JZCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 215.00
Bid: 192.00
Ask: 238.00
Change: 0.00 (0.00%)
Spread: 46.00 (23.958%)
Open: 215.00
High: 216.00
Low: 215.00
Prev. Close: 215.00
JZCP Live PriceLast checked at -
JZ Capital Partners is an Investment Trust

The strategy is to realise investments, pay down debt and reduce commitments to new investments. In addition, the company will return capital to Shareholders while meeting the capital requirements of the portfolio in order to achieve NAV growth.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update in relation to Secondary Sale

14 Dec 2023 07:00

JZ Capital Partners Ltd - Update in relation to Secondary Sale

JZ Capital Partners Ltd - Update in relation to Secondary Sale

PR Newswire

LONDON, United Kingdom, December 14

JZ CAPITAL PARTNERS LIMITED (the "Company" or "JZCP")

(a closed-ended investment company incorporated with limited liability under the laws of Guernsey with registered number 48761)

 

LEI 549300TZCK08Q16HHU44

 

Update in relation to Secondary Sale

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014, WHICH FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR").

14 December 2023

JZ Capital Partners Limited, the London listed fund that has investments in US and European microcap companies and US real estate, is pleased to provide an update in relation to its interest in the secondary fund, JZHL Secondary Fund LP (the "Secondary Fund"), to which JZCP earlier sold its interests in certain US microcap portfolio companies (the "Secondary Sale"). The Secondary Sale was announced on 19 October 2020, with further details of the sale being included in a circular sent to shareholders of the Company dated 29 October 2020.

JZCP is pleased to announce that the Secondary Fund has sold its interest in Felix Storch Holdings, LLC ("Felix Storch") for consideration of approximately US$167.7 million.

Shareholders are reminded that, as detailed in the aforementioned announcement and circular, JZCP received as consideration for the Secondary Sale, and in addition to the previously received approximately US$90 million in cash, a special limited partner interest in the Secondary Fund entitling JZCP to certain distributions and other rights and obligations from the Secondary Fund (the "Special LP Interest"). Any distributions to be received by JZCP as a result of its Special LP Interest are subject to an agreed distribution waterfall as detailed in the aforementioned announcement and circular which provides that, once the other investors in the Secondary Fund have received their initial required distributions determined by reference to their respective contributions to the Secondary Fund and amounting to approximately US$132.6 million, in aggregate, JZCP is entitled to receive as distributions from the Secondary Fund: (i) 95 per cent. of all distributions until it has received distributions equal to US$67.6 million; and (ii) thereafter, 37.5 per cent. of all distributions.

In accordance with the agreed distribution waterfall described above, JZCP will receive a distribution from the Secondary Fund of approximately US$62.5 million in connection with the sale of Felix Storch, which would correspond to a NAV uplift to JZCP of approximately 19 cents per ordinary share. JZCP’s remaining interest in the Secondary Fund, based on pro forma financials as at 31 August 2023, is valued at approximately US$32.5 million.

The sale of Felix Storch follows the previously announced disposals of certain interests in the Secondary Fund, in connection with which JZCP received aggregate distribution proceeds of US$97.4 million. The Company will make further announcements in relation to any further distributions of the Secondary Fund as and when appropriate.

The Company notes that its only outstanding debt obligation is approximately US$45.0 million (plus accrued interest) under the Company's senior facility provided by WhiteHorse Capital Management, LLC due on 26 January 2027. The Company remains focused on the implementation of the new investment policy to realise maximum value from the Company's investments and, after the repayment of all debt, to return capital to shareholders. To that end and in accordance with the investment policy, the Company intends to use the proceeds from the sale of Felix Storch to repay its senior facility in full. This repayment will, subject to retaining sufficient funds to cover existing obligations and support certain existing investments to maximise their value, enable the Company to plan to commence making distributions to shareholders, as previously announced in the Company's interim report and financial statements released on 9 November 2023. The Company will make further announcements regarding the repayment of the senior facility as and when appropriate.

Market Abuse Regulation

The information contained within this announcement is considered by the Company to constitute inside information as stipulated under MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

The person responsible for arranging the release of this announcement on behalf of the Company is Sharon Parr, Board member of JZCP.

______________________________________________________________________________________

For further information:

 

Kit Dunford / Ed BerryFTI Consulting

+44 (0)7717 417 038 / +44 (0)7703 330 199

David ZalaznickJordan/Zalaznick Advisers, Inc.

+1 (212) 485 9410

Hannah HaywardNorthern Trust International Fund Administration Services (Guernsey) Limited

+44 (0) 1481 745417

 

Important Notice

This announcement includes statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements relate to matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Forward-looking statements are not guarantees of future performance. The Company's actual investment performance, results of operations, financial condition, liquidity, policies and the development of its strategies may differ materially from the impression created by the forward-looking statements contained in this announcement. In addition, even if the investment performance, result of operations, financial condition, liquidity and policies of the Company and development of its strategies are consistent with the forward-looking statements contained in this announcement, those results or developments may not be indicative of results or developments in subsequent periods. These forward-looking statements speak only as at the date of this announcement. Subject to their legal and regulatory obligations, each of the Company, Jordan/Zalaznick Advisers, Inc. and their respective affiliates expressly disclaims any obligations to update, review or revise any forward-looking statement contained herein whether to reflect any change in expectations with regard thereto or any change in events, conditions or circumstances on which any statement is based or as a result of new information, future developments or otherwise.



Date   Source Headline
18th May 20127:00 amRNSFull Year Results 2011
17th May 20127:00 amRNSNet Asset Value(s)
27th Apr 20129:07 amRNSNet Asset Value(s)
17th Apr 20124:04 pmRNSNotice of Results - Replacement
13th Apr 20128:57 amRNSNotice of Results
24th Feb 201210:05 amRNSNew Accounting Ref Date
23rd Feb 20129:23 amRNSNet Asset Value(s)
25th Jan 20125:02 pmRNSHolding(s) in Company
25th Jan 20122:17 pmRNSTotal Voting Rights
20th Jan 20124:49 pmRNSHolding(s) in Company
19th Jan 20125:31 pmRNSDirector/PDMR Shareholding
19th Jan 20125:30 pmRNSDirector/PDMR Shareholding
19th Jan 20125:29 pmRNSDirector/PDMR Shareholding
19th Jan 20125:27 pmRNSDirector/PDMR Shareholding
17th Jan 20129:22 amRNSNet Asset Value(s)
16th Jan 201211:46 amRNSHolding(s) in Company
10th Jan 20123:33 pmRNSHolding(s) in Company
29th Dec 201110:03 amRNSHolding(s) in Company
28th Dec 20119:34 amRNSNet Asset Value(s)
22nd Dec 20115:23 pmRNSDirector/PDMR Shareholding
22nd Dec 20119:43 amRNSHolding(s) in Company
20th Dec 20117:00 amRNSJZCP Q3 Interim Management Statement
14th Dec 201111:23 amRNSHolding(s) in Company
6th Dec 20111:58 pmRNSHolding(s) in Company
2nd Dec 20117:00 amRNSCompletes Sale of Wound Care Holdings LLC
1st Dec 20119:17 amRNSConversion of Securities
23rd Nov 20114:17 pmRNSNet Asset Value(s)
31st Oct 20119:52 amRNSNet Asset Value(s)
25th Oct 20112:55 pmRNSDisposal
20th Oct 20114:28 pmRNSHolding(s) in Company
19th Oct 20112:02 pmRNSDividend Declaration
18th Oct 20113:58 pmRNSNet Asset Value(s)
18th Oct 20117:00 amRNSInterim Results 2011
10th Oct 201110:48 amRNSHolding(s) in Company
5th Oct 20119:25 amRNSHolding(s) in Company
27th Sep 20119:28 amRNSHolding(s) in Company
16th Sep 20118:58 amRNSNotice of Interim Results
25th Aug 20117:00 amRNSConversion of Shares
12th Aug 20118:18 amRNSNet Asset Value(s)
18th Jul 20117:00 amRNSAcquisition and realisation of Investments
13th Jul 20118:30 amRNSNet Asset Value(s)
28th Jun 20115:01 pmRNSResult of AGM
21st Jun 201112:44 pmRNSNet Asset Value(s)
21st Jun 20117:00 amRNSInterim Management Statement
26th May 20118:10 amRNSNet Asset Value(s)
24th May 20116:01 pmRNSNotice of AGM
12th May 20118:53 amRNSNet Asset Value(s)
9th May 20113:36 pmRNSDividend Declaration
9th May 20117:00 amRNSAnnual Results for Period Ending 28 February 2011
3rd May 20112:26 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.